Showing 1 - 5 results of 5 for search 'Dana K. Mitchell', query time: 0.03s
Refine Results
-
1
SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA‐deficient cells by Ka‐Kui Chan, Zahi Abdul‐Sater, Aditya Sheth, Dana K. Mitchell, Richa Sharma, Donna M. Edwards, Ying He, Grzegorz Nalepa, Steven D. Rhodes, D. Wade Clapp, Elizabeth A. Sierra Potchanant
Published 2022-02-01
Article -
2
Mitotic Errors Promote Genomic Instability and Leukemia in a Novel Mouse Model of Fanconi Anemia by Donna M. Edwards, Donna M. Edwards, Donna M. Edwards, Dana K. Mitchell, Dana K. Mitchell, Zahi Abdul-Sater, Zahi Abdul-Sater, Ka-Kui Chan, Ka-Kui Chan, Zejin Sun, Aditya Sheth, Aditya Sheth, Ying He, Li Jiang, Jin Yuan, Richa Sharma, Richa Sharma, Magdalena Czader, Pei-Ju Chin, Yie Liu, Guillermo de Cárcer, Grzegorz Nalepa, Grzegorz Nalepa, Grzegorz Nalepa, Grzegorz Nalepa, Hal E. Broxmeyer, D. Wade Clapp, D. Wade Clapp, D. Wade Clapp, D. Wade Clapp, Elizabeth A. Sierra Potchanant, Elizabeth A. Sierra Potchanant
Published 2021-11-01
Article -
3
A multicenter cross-sectional study in infants with congenital heart defects demonstrates high diagnostic yield of genetic testing but variable evaluation practices by Matthew D. Durbin, Lindsey R. Helvaty, Ming Li, William Border, Sara Fitzgerald-Butt, Vidu Garg, Gabrielle C. Geddes, Benjamin M. Helm, Seema R. Lalani, Kim L. McBride, Alexis McEntire, Dana K. Mitchell, Chaya N. Murali, Stephanie B. Wechsler, Benjamin J. Landis, Stephanie M. Ware
Published 2023-01-01
Article -
4
New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types by Silpa Gampala, Hye-ran Moon, Randall Wireman, Jacqueline Peil, Sonia Kiran, Dana K. Mitchell, Kylee Brewster, Henry Mang, Andi Masters, Christine Bach, Whitney Smith-Kinnamen, Emma H. Doud, Ratan Rai, Amber L. Mosley, Sara K. Quinney, D. Wade Clapp, Chafiq Hamdouchi, James Wikel, Chi Zhang, Bumsoo Han, Millie M. Georgiadis, Mark R. Kelley, Melissa L. Fishel
Published 2024-03-01
Article -
5
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition by Evan DuBose, Evan DuBose, Samantha M. Bevill, Samantha M. Bevill, Dana K. Mitchell, Noah Sciaky, Brian T. Golitz, Shelley A. H. Dixon, Steven D. Rhodes, Steven D. Rhodes, Steven D. Rhodes, Steven D. Rhodes, James E. Bear, James E. Bear, James E. Bear, Gary L. Johnson, Gary L. Johnson, Steven P. Angus, Steven P. Angus, Steven P. Angus, Steven P. Angus, Steven P. Angus
Published 2024-05-01
Article